Biothrax Injection, Suspension
Product Images NDC 64678-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Biothrax (NDC 64678-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biodefense Operations Lansing, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biothrax Vaccine (5mL Vial Label)

Biothrax Vaccine (5mL Vial Label)
Label for BioThrax Anthrax Vaccine Adsorbed injection, a suspension vaccine manufactured by Emergent BioDefense Operations Lansing, LLC. The label indicates an NDC of 64678-211-05, contains 5 mL (0.5 mL per dose), and includes storage instructions to keep refrigerated between 2-8°C and not to freeze. The product is Rx only and licensed under U.S. License No. 1755.*
FDA Label Image

Biothrax Vaccine (5mL Vial Carton)

Biothrax Vaccine (5mL Vial Carton)
Packaging label for BioThrax Anthrax Vaccine Adsorbed injection, suspension, containing 100 ug/mL. The label shows a 5 mL multidose vial, for intramuscular or subcutaneous use, manufactured by Emergent BioDefense Operations Lansing LLC. The label includes storage instructions and product identification with NDC 64678-211-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.